Skip to main content
Gaush Meditech Ltd logo

Gaush Meditech Ltd — Investor Relations & Filings

Ticker · 2407 ISIN · KYG3902N1051 LEI · 254900I4OJB732KGP619 HKEX Manufacturing
Open in API
Filings indexed 164 across all filing types
Latest filing 2023-03-31 Annual Report
Country KY Cayman Islands
Listing HKEX 2407

About Gaush Meditech Ltd

http://www.gaush.com

Gaush Meditech Ltd. is a technology group dedicated to the ophthalmic medical sector, integrating research and development, manufacturing, sales, training, and technical services. The company provides a broad spectrum of high-quality ophthalmic medical devices, equipment, and consumables. Its comprehensive portfolio includes diagnostic equipment, surgical instruments, and treatment devices, serving the specialized needs of eye care professionals. The company leverages over two decades of experience in this field.

Recent filings

Filing Released Lang Actions
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
Annual Report Classification · 95% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022' and contains detailed financial data including revenue, loss, adjusted net profit, and segment breakdowns for the full fiscal year 2022. It includes a management discussion and analysis section, business review, product portfolio, R&D efforts, and technical services business overview. The length is substantial (15,000 characters) and the content is comprehensive, covering full-year financial performance and business operations. This matches the characteristics of an Annual Report (10-K) rather than a short announcement or summary. There is no indication that this is merely an announcement of a report or a certification document. Therefore, the document should be classified as an Annual Report (10-K).
2023-03-31 English
VOLUNTARY ANNOUNCEMENT - COOPERATION WITH HAAG-STREIT ON DISTRIBUTION OF CERTAIN OPHTHALMIC MEDICAL DEVICES
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Gaush Meditech Ltd regarding a new cooperation agreement with HAAG-STREIT for distribution of ophthalmic medical devices. It is an announcement of a business development event, not a financial report, regulatory filing, or meeting material. The document is relatively short (4224 characters) and does not contain financial statements, voting results, or management changes. It is not a report publication announcement since it does not mention any report being published or attached. The content fits best under a general regulatory announcement category for business updates that do not fit other specific categories.
2023-03-24 English
NOTICE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is a short announcement from Gaush Meditech Ltd regarding a scheduled Board meeting to consider and approve the annual results for the year ended December 31, 2022, and the recommendation for a final dividend. It does not contain any financial data or the actual annual report but merely notifies the market of the upcoming board meeting and the agenda. The document length is only 1548 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about the timing of report approval and publication are classified as Report Publication Announcements (RPA).
2023-03-20 English
PROFIT UPDATE IN RESPECT OF THE FINANCIAL INFORMATION FOR THE FINANCIAL YEAR ENDED DECEMBER 31, 2022
Earnings Release Classification · 95% confidence The document is an announcement titled 'PROFIT UPDATE IN RESPECT OF THE FINANCIAL INFORMATION FOR THE FINANCIAL YEAR ENDED DECEMBER 31, 2022' by Gaush Meditech Ltd. It provides preliminary unaudited financial information and expected results for the full financial year 2022, including net loss and adjusted net profit estimates. The announcement states that the final audited annual results are still being finalized and will be published later. The document is about informing shareholders and investors of expected financial performance based on management accounts, not the full official annual report itself. It is a profit update announcement related to the annual financial year but does not contain full audited financial statements or comprehensive analysis. The document length is 6080 characters, which is relatively short and typical for an earnings or profit update announcement. It is not a full Annual Report (10-K), nor an Interim Report (IR), nor a Management Discussion & Analysis (MDA). It is also not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains substantive financial information and analysis, not just a notice or certification. The document fits best as an Earnings Release (ER) type, which is the initial announcement of yearly financial results highlights before the full annual report is published.
2023-03-16 English
VOLUNTARY ANNOUNCEMENT - COOPERATION WITH GEUDER ON LOCALIZATION OF MEDICAL DEVICE FOR VITRECTOMY
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Gaush Meditech Ltd regarding a new cooperation agreement with Geuder AG for localization of a medical device. It is an announcement of a business development event, not a financial report or regulatory filing. The document is relatively short (3,672 characters) and does not contain financial statements, audit information, or detailed management discussion. It does not announce voting results, changes in management, or capital structure changes. It is clearly a business update announcement. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-03-15 English
VOLUNTARY ANNOUNCEMENT INCLUSION AS AN ELIGIBLE STOCK OF THE SHANGHAI-HONG KONG STOCK CONNECT AND THE SHENZHEN-HONG KONG STOCK CONNECT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Gaush Meditech Ltd regarding the inclusion of its shares as eligible stocks in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs. It is an announcement about a change in the trading eligibility and market access of the company's shares, not a financial report, earnings release, or regulatory filing about financial results. The document is relatively short (3320 characters) and does not contain financial statements or detailed financial data. It is not a report publication announcement since it does not mention any report being published or attached. The content fits best under a general regulatory announcement category about market listing or trading eligibility changes. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-13 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.